Drug Company Gift Disclosure Act

Summary

Drug Company Gift Disclosure Act - Amends the Federal Food, Drug, and Cosmetic Act to require drug manufacturers, packers, and distributors to disclose to the Commissioner of Food and Drugs the value, nature, and purpose of: (1) gifts made to covered health entities in connection with marketing activities; and (2) cash rebates, discounts, or any other financial consideration to any pharmaceutical benefit manager in connection with marketing activities. Makes such information available to the public, but retains the confidentiality of trade secrets. Establishes civil penalties for violations.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 13 February 2003

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 13 February 2003

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 13 February 2003

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.